Surface Coating for Specific CTC Capture and Clean Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for detecting and isolating circulating tumor cells (CTCs) suffer from low detection rates due to non-specific binding of blood cells, necessitating a more specific and effective method for capture and release of CTCs and other biological substances.
Innovation Solution
A surface coating comprising a nonfouling composition to reduce non-specific binding, a bioactive composition to capture target cells, and a releasable composition to purify and release non-specific cells, combined with a linker composition to attach these layers, and a microfluidic device design for enhanced capture efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If anti-EpCAM antibody-coated magnetic nanoparticles are used to capture CTCs, then CTC enrichment is achieved, but non-specific binding of blood cells reduces detection rate
Solution Approach 1:
The surface coating is segmented into distinct functional layers: a nonfouling composition layer (e.g., PEG) that repels non-specific blood cells, and a bioactive composition layer (anti-EpCAM antibodies) that specifically captures CTCs. This segmentation allows each layer to perform its specialized function without interference, resolving the contradiction between specific capture and non-specific binding reduction
Solution Approach 2:
The invention uses a composite surface coating combining chemically distinct materials: a nonfouling polymer matrix (such as polyethylene glycol) embedded with bioactive targeting molecules (anti-EpCAM antibodies). This composite structure integrates the anti-fouling properties of the polymer with the specific binding capability of the antibodies, simultaneously achieving both CTC enrichment and reduction of non-specific blood cell binding
2Object-generated harmful factors
If surface modification with bioinert materials is applied to reduce non-specific binding, then blood cell binding is reduced, but capture efficiency of target cells may be compromised
Solution Approach 1:
The surface coating exhibits local quality variations: the bulk nonfouling composition provides anti-adhesive properties throughout the surface, while localized clusters of bioactive antibodies provide specific capture functionality. This spatial differentiation of properties ensures that non-specific binding is reduced across the entire surface while maintaining high capture efficiency at antibody locations
Solution Approach 2:
The nonfouling composition acts as an intermediary layer between the solid substrate and the bioactive antibodies. It mediates the interaction by providing a anti-adhesive environment that prevents non-specific blood cell binding while allowing the embedded antibodies to maintain their specific binding capability to CTCs, thus resolving the contradiction between non-specific binding reduction and capture efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The surface coating significantly enhances the capture and release of CTCs while minimizing non-specific binding, allowing for efficient purification and subsequent analysis of these cells.
Implementation Method 1
a nonfouling composition that reduces the binding of nonspecific blood cells and adsorption of other blood components
Implementation Method 2
a bioactive composition that captures a CRC
Implementation Method 3
a releasable composition that enables release of the captured biological substance
Data Source
AI summary
This invention relates to a surface coating for capture circulating rare cells, comprising a nonfouling composition to prevent the binding of non-specific cells and adsorption of serum components; a bioactive composition for binding the biological substance, such as circulating tumor cells; with or without a linker composition that binds the nonfouling and bioactive compositions. The invention also provide a surface coating for capture and purification of a biological substance, comprising a releasable composition to release the non-specific cells and other serum components; a bioactive composition for binding the biological substance, such as circulating tumor cells; with or without a linker composition that binds the releasable and bioactive compositions. The present invention also discloses a novel microfluidic chip, with specific patterned microstructures to create a flow disturbance and increase the capture rate of the biological substance.